fda there is no easy road, page-8

Heah Pat,

As you are aware Thoratec is a large company with more than just LVAD's as there products, hence there are possibly other areas within the organisation that are losing money. I'm sure if each category was seperated it would show that the LVAD part would be profitable.

VCR is solely a LVAD company which in my view is good news for its investors if the take up of the Ventrassist is good. If it doesn't take off then there up s..t creek. Maybe thats why institutions and the like aren't taking a position yet.

Be good to get some info from the company this week...the SP is looking depressed.